Sitter Kailyn E, Wong Denise H, Bolton Rendelle E, Vimalananda Varsha G
Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System, Bedford, MA 01730, USA.
J Endocr Soc. 2022 Jun 6;6(8):bvac089. doi: 10.1210/jendso/bvac089. eCollection 2022 Aug 1.
Outpatient endocrinology care delivered by telehealth is likely to remain common after the pandemic. There are few data to guide endocrinologists' judgments of clinical appropriateness (safety and effectiveness) for telehealth by synchronous video. We examined how, in the absence of guidelines, endocrinologists determine clinical appropriateness for telehealth, and we identified their strategies to navigate barriers to safe and effective use.
We conducted qualitative, semi-structuredinterviews with 26 purposively selected US endocrinologists. We used a directed content analysis to characterize participant perceptions of which patients and situations were clinically appropriate for telehealth and to identify adaptations they made to accommodate telehealth visits.
Endocrinologists' perspectives about appropriateness for telehealth were influenced by clinical considerations, nonclinical patient factors, and the type and timing of the visit. These factors were weighed differently across individual participants according to their risk tolerance, values related to the physical examination and patient relationships, and impressions of patient capabilities and preferences. Some participants made practice adaptations that increased their comfort offering telehealth to a wider swath of patients.
Endocrinologists' judgments about clinical appropriateness of telehealth for different patient situations varied widely across participants. The risk of such divergent approaches to determining appropriateness is unintended and clinically unwarranted variation in use of telehealth, compromising quality of care. Expert consensus is needed to guide endocrinologists now, along with studies to anchor future evidence-based guidelines for determining clinical appropriateness of telehealth in endocrinology.
疫情过后,通过远程医疗提供的门诊内分泌科护理可能仍会很常见。几乎没有数据可指导内分泌科医生对同步视频远程医疗的临床适宜性(安全性和有效性)做出判断。我们研究了在内分泌科医生缺乏相关指南的情况下,他们如何确定远程医疗的临床适宜性,以及他们应对安全有效使用远程医疗的障碍的策略。
我们对26名美国内分泌科医生进行了定性、半结构化访谈,这些医生是经过有目的的挑选的。我们采用定向内容分析法,以描述参与者对哪些患者和情况适合远程医疗的看法,并确定他们为适应远程医疗就诊所做的调整。
内分泌科医生对远程医疗适宜性的看法受到临床因素、非临床患者因素以及就诊类型和时间的影响。根据个体参与者的风险承受能力、与体格检查和患者关系相关的价值观,以及对患者能力和偏好的印象,这些因素在不同参与者中的权重有所不同。一些参与者进行了实践调整,从而更放心地为更广泛的患者群体提供远程医疗服务。
内分泌科医生对不同患者情况的远程医疗临床适宜性的判断在参与者之间差异很大。这种确定适宜性的不同方法存在风险,即远程医疗的使用会出现意外且临床上不合理的差异,从而影响医疗质量。目前需要专家共识来指导内分泌科医生,同时也需要开展相关研究,为未来制定内分泌科远程医疗临床适宜性的循证指南提供依据。